Basic info
Industry
biotechnology research
Sectors
Biotechnology
specialty
Epilepsy
CNS
Pharmaceuticals
Date founded
2019
Funding rounds raised
Total raised
$179M
from 12 investors over 12 rounds
A
Arvelle Therapeutics raised $43M on May 27, 2020
Investors: H.I.G. BioVentures, KB Investment, Andera Partners, -, EQT Life Sciences, BPV Capital Management - Back Porch Vista and F-Prime Capital Partners
A
Arvelle Therapeutics raised $179M on February 18, 2019
Investors: H.I.G. BioVentures, Andera Partners, BPV Capital Management - Back Porch Vista, EQT Life Sciences and NovaQuest Capital Management